James D. Dunbar

3.8k total citations · 1 hit paper
23 papers, 3.1k citations indexed

About

James D. Dunbar is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, James D. Dunbar has authored 23 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in James D. Dunbar's work include Fibroblast Growth Factor Research (9 papers), Kruppel-like factors research (7 papers) and Epigenetics and DNA Methylation (6 papers). James D. Dunbar is often cited by papers focused on Fibroblast Growth Factor Research (9 papers), Kruppel-like factors research (7 papers) and Epigenetics and DNA Methylation (6 papers). James D. Dunbar collaborates with scholars based in United States, United Kingdom and Sweden. James D. Dunbar's co-authors include Alexei Kharitonenkov, David B. Donner, Tamer Coşkun, Holly A. Bina, M. Schneider, David E. Moller, Yanyun Chen, Lindsey D. Mayo, Robert S. Warren and Radmila Micanovic and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and The Journal of Immunology.

In The Last Decade

James D. Dunbar

23 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibroblast Growth Factor 21 Corrects Obesity in Mice

2008 890 citations Tamer Coşkun, Holly A. Bina et al. Endocrinology profile →

Peers

Countries citing papers authored by James D. Dunbar

Since Specialization

Citations

This map shows the geographic impact of James D. Dunbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Dunbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Dunbar more than expected).

Fields of papers citing papers by James D. Dunbar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D. Dunbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Dunbar. The network helps show where James D. Dunbar may publish in the future.

Co-authorship network of co-authors of James D. Dunbar

This figure shows the co-authorship network connecting the top 25 collaborators of James D. Dunbar. A scholar is included among the top collaborators of James D. Dunbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D. Dunbar. James D. Dunbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist 2023 ·Cell Metabolism ·Olivier Bénichou, Tamer Coşkun, Malgorzata D. Gonciarz, Parag Garhyan, Andrew C. Adams, Yu Du, James D. Dunbar, Jennifer A. Martin, Kieren J. Mather, Richard T. Pickard, Vincent L. Reynolds, Deborah A. Robins, (unknown), Paul J. Emmerson	52
2	DYRK1B inhibition exerts senolytic effects on endothelial cells and rescues endothelial dysfunctions 2023 ·Mechanisms of Ageing and Development ·(unknown), (unknown), Chantelle Hudson, James D. Dunbar, (unknown), (unknown), Andrea Taddei, Edoardo Mazza, Costanza Giampietro	10
3	GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior 2022 ·Diabetes ·Ricardo J. Samms, Richard Cosgrove, (unknown), (unknown), Brian A. Droz, Daniel A. Briere, James D. Dunbar, Mridula Dogra, Jorge Alsina‐Fernandez, Tito Borner, Bart C. De Jonghe, Matthew R. Hayes, Tamer Coşkun, Kyle W. Sloop, Paul J. Emmerson, Minrong Ai	46
4	The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling 2020 ·eLife ·(unknown), (unknown), (unknown), (unknown), Giuseppe D’Agostino, Garron T. Dodd, Frank Reimann, Fiona M. Gribble, (unknown), James D. Dunbar, (unknown), Dana K. Sindelar, Tamer Coşkun, Paul J. Emmerson, Simon M. Luckman	63
5	Rational Design of a Fibroblast Growth Factor 21-Based Clinical Candidate, LY2405319 2013 ·PLoS ONE ·Alexei Kharitonenkov, John M. Beals, Radmila Micanovic, Beth A. Strifler, (unknown), Victor J. Wroblewski, Shun Li, Anja Köester, Amy Ford, Tamer Coşkun, James D. Dunbar, Christine C. Cheng, Christopher C. Frye, Thomas F. Bumol, David E. Moller	146
6	FGF21 as a Therapeutic Reagent 2012 ·Advances in experimental medicine and biology ·Yang Zhao, James D. Dunbar, Alexei Kharitonenkov	28
7	Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo 2012 ·PLoS ONE ·Andrew C. Adams, Tamer Coşkun, (unknown), M. Schneider, (unknown), Radmila Micanovic, Holly A. Bina, James D. Dunbar, Alexei Kharitonenkov	101
8	Sall2 is a novel p75NTR‐interacting protein that links NGF signalling to cell cycle progression and neurite outgrowth 2009 ·The EMBO Journal ·Roxana Pincheira, Melinda R. Baerwald, James D. Dunbar, David B. Donner	39
9	FGF21 attenuates lipolysis in human adipocytes – A possible link to improved insulin sensitivity 2008 ·FEBS Letters ·Peter Arner, Amanda Pettersson, Pamela J. Mitchell, James D. Dunbar, Alexei Kharitonenkov, Mikael Rydén	206
10	Different roles of N‐ and C‐ termini in the functional activity of FGF21 2008 ·Journal of Cellular Physiology ·Radmila Micanovic, (unknown), James D. Dunbar, David A. Driver, Holly A. Bina, Craig D. Dickinson, Alexei Kharitonenkov	108
11	Fibroblast Growth Factor 21 Corrects Obesity in Mice breakdown → 2008 ·Endocrinology ·Tamer Coşkun, Holly A. Bina, M. Schneider, James D. Dunbar, (unknown), Yanyun Chen, David E. Moller, Alexei Kharitonenkov	890
12	FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlotho 2007 ·Journal of Cellular Physiology ·Alexei Kharitonenkov, James D. Dunbar, Holly A. Bina, Stuart W. Bright, Julie S. Moyers, Chen Zhang, Liyun Ding, Radmila Micanovic, (unknown), Michael D. Knierman, John E. Hale, Tamer Coşkun, Armen B. Shanafelt	284
13	Molecular determinants of FGF‐21 activity—synergy and cross‐talk with PPARγ signaling 2006 ·Journal of Cellular Physiology ·Julie S. Moyers, Tatiyana L. Shiyanova, (unknown), James D. Dunbar, Timothy W. Noblitt, Keith A. Otto, Anne Reifel‐Miller, Alexei Kharitonenkov	159
14	Utilization of Distinct Signaling Pathways by Receptors for Vascular Endothelial Cell Growth Factor and Other Mitogens in the Induction of Endothelial Cell Proliferation 2000 ·Journal of Biological Chemistry ·Li‐Wha Wu, Lindsey D. Mayo, James D. Dunbar, (unknown), Melinda R. Baerwald, Eric Jaffe, Dongfang Wang, Robert S. Warren, David B. Donner	251
15	Tumor Necrosis Factor Employs a Protein-tyrosine Phosphatase to Inhibit Activation of KDR and Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation 2000 ·Journal of Biological Chemistry ·(unknown), Li‐Wha Wu, James D. Dunbar, Osman N. Özeş, Lindsey D. Mayo, (unknown), Jason A. Gustin, Melinda R. Baerwald, Eric Jaffe, Robert S. Warren, David B. Donner	98
16	VRAP Is an Adaptor Protein That Binds KDR, a Receptor for Vascular Endothelial Cell Growth Factor 2000 ·Journal of Biological Chemistry ·Li‐Wha Wu, Lindsey D. Mayo, James D. Dunbar, (unknown), Osman N. Özeş, Robert S. Warren, David B. Donner	95
17	Induction of Jak/STAT Signaling by Activation of the Type 1 TNF Receptor 1998 ·The Journal of Immunology ·(unknown), James D. Dunbar, Chuan Yang, Lawrence M. Pfeffer, David B. Donner	151
18	Two-hybrid cloning of a gene encoding TNF receptor-associated protein 2, a protein that interacts with the intracellular domain of the type 1 TNF receptor: identity with subunit 2 of the 26S protease 1997 ·The Journal of Immunology ·James D. Dunbar, Hyungjun Song, (unknown), Li‐Wha Wu, David B. Donner	20
19	Inhibition of Tumor Necrosis Factor Signal Transduction in Endothelial Cells by Dimethylaminopurine 1996 ·Journal of Biological Chemistry ·Michael W. Marino, James D. Dunbar, Li‐Wha Wu, (unknown), (unknown), (unknown), Masayuki Matsushita, Angus C. Nairn, Yuhua Zhang, Richard Kolesnick, Eric Jaffe, David B. Donner	30
20	Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system. 1994 ·Journal of Biological Chemistry ·Hyungjun Song, James D. Dunbar, David B. Donner	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact